Knee and other joint arthritis tissue therapy
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests a regenerative therapy made from a patient’s own fat tissue (a “cellular” treatment) to reduce pain and improve function in arthritis-related problems. It may help people with inflammatory or degenerative arthritis changes, if they meet safety and tissue-donation requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have arthritis-related wear-and-tear or inflammation in specific areas (often knee or hip, but also shoulder, Achilles tendon, sacroiliac joint, wrist/hand, foot/ankle, or plantar fasciitis)
- Your doctor feels you don’t have other major medical problems that would make the procedure unsafe for you
- You can understand the study and agree to the consent form
- You can provide enough donor tissue for the treatment (from around blood vessels and the tissue matrix, as directed by the study team)
- You are healthy enough to tolerate the procedure and complete follow-up visits and tracking
- You do not have key safety exclusions (like active infection or certain medications/conditions) as judged by the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two natural treatments—one made from your own blood (platelet-rich plasma) and one from your own fat cells—can relieve knee osteoarthritis pain when injected into the knee. The goal is to see if these injections reduce pain and improve knee function without surgery.
This Phase 2 study tests a patient’s own (autologous) regenerative cell treatment to reduce knee pain and inflammation from osteoarthritis. It mainly looks at whether the treatment is safe and whether it can improve symptoms over time.
This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.
This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.
This trial tests a treatment using your own (autologous) regenerative cells to reduce pain and inflammation from shoulder osteoarthritis. It may help people with long-lasting shoulder pain, but you must meet several health and medication timing requirements.
This study uses fat tissue from your own body, processed with a special device, and injects it into the knee to help reduce pain and improve function in knee osteoarthritis. It's a minimally invasive treatment that might be an option for people who have not found relief from other treatments.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.